Identification of biomarkers and pathways in hypertensive nephropathy based on the ceRNA regulatory network

Zhen Wang1, Zhongjie Liu1, Yingxia Yang1

  • 1Nephrology Department, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No.5 Haiyuncang Road, Dongcheng District, Beijing, 100700, China.

BMC Nephrology
|November 12, 2020
PubMed

Insights

This study identifies key RNA biomarkers, including specific microRNAs and long non-coding RNAs, involved in the insulin signaling pathway, offering new insights into hypertensive nephropathy mechanisms.

Area of Science:

  • Genomics and Molecular Biology
  • Renal Physiology
  • Biomarker Discovery

Background:

  • Hypertensive nephropathy (HTN) is a significant cause of renal injury due to chronic hypertension.
  • Understanding the molecular mechanisms and identifying biomarkers for HTN is crucial for patient outcomes.

Purpose of the Study:

  • To identify potential biomarkers for hypertensive nephropathy (HTN).
  • To elucidate the underlying molecular mechanisms of HTN development.

Main Methods:

  • Downloaded and analyzed gene expression data (GSE28260) from hypertensive and normotensive individuals.
  • Identified differentially expressed RNAs (DERs) and constructed a competing endogenous RNA (ceRNA) network.
  • Performed functional enrichment analyses (DAVID, GSEA) and KEGG pathway analysis.

Main Results:

  • Identified 947 DERs, including 900 DE-mRNAs, 20 DE-lncRNAs, and 27 DE-miRNAs.
  • lncRNAs KCTD21-AS1, LINC00470, and SNHG14 were identified as hub nodes in the ceRNA network.
  • The insulin signaling pathway was found to be directly associated with HTN, regulated by specific mRNAs, miRNAs, and lncRNAs.

Conclusions:

  • The insulin signaling pathway is directly implicated in hypertensive nephropathy.
  • Specific microRNA (has-miR-107) and lncRNAs (SNHG14, TUG1, ZNF252P-AS1, MIR503HG) serve as potential biomarkers for HTN.
  • Findings enhance understanding of HTN pathogenesis and progression.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
492
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
375
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
6.2K